- Home
- HIHO vs MBIO Comparison
HIHO vs MBIO Comparison
Compare HIHO & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- MBIO
- Stock Information
- Founded
- HIHO 1990
- MBIO 2015
- Country
- HIHO Hong Kong
- MBIO United States
- Employees
- HIHO N/A
- MBIO N/A
- Industry
- HIHO Industrial Machinery/Components
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- MBIO Health Care
- Exchange
- HIHO Nasdaq
- MBIO Nasdaq
- Market Cap
- HIHO 7.1M
- MBIO 7.3M
- IPO Year
- HIHO 1996
- MBIO N/A
- Fundamental
- Price
- HIHO $1.94
- MBIO $1.12
- Analyst Decision
- HIHO
- MBIO Strong Buy
- Analyst Count
- HIHO 0
- MBIO 1
- Target Price
- HIHO N/A
- MBIO $100.00
- AVG Volume (30 Days)
- HIHO 30.8K
- MBIO 1.1M
- Earning Date
- HIHO 01-21-2025
- MBIO 05-27-2025
- Dividend Yield
- HIHO 6.21%
- MBIO N/A
- EPS Growth
- HIHO N/A
- MBIO N/A
- EPS
- HIHO N/A
- MBIO N/A
- Revenue
- HIHO $7,345,000.00
- MBIO N/A
- Revenue This Year
- HIHO N/A
- MBIO N/A
- Revenue Next Year
- HIHO N/A
- MBIO N/A
- P/E Ratio
- HIHO N/A
- MBIO N/A
- Revenue Growth
- HIHO 11.36
- MBIO N/A
- 52 Week Low
- HIHO $1.39
- MBIO $1.01
- 52 Week High
- HIHO $2.88
- MBIO $65.00
- Technical
- Relative Strength Index (RSI)
- HIHO 73.09
- MBIO 36.90
- Support Level
- HIHO $1.74
- MBIO $1.01
- Resistance Level
- HIHO $2.00
- MBIO $1.22
- Average True Range (ATR)
- HIHO 0.10
- MBIO 0.07
- MACD
- HIHO 0.04
- MBIO 0.02
- Stochastic Oscillator
- HIHO 85.71
- MBIO 52.38
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.